Be Biopharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 84

Employees

  • Latest Deal Type
  • Out of Business

Be Biopharma General Information

Description

Developer of engineered B-cell medicines intended to transform treatment for patients with serious diseases. The company's drugs address major hurdles of cell and gene therapies and are durable, re-enable, and can be administered without toxic conditioning, enabling healthcare professionals to treat diseases like cancer, autoimmune conditions, and enzyme deficiency while providing targeted, effective care for patients.

Contact Information

Website
www.be.bio
Formerly Known As
Pulsar Biopharma
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • One Kendall Square
  • B200, Third Floor
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • One Kendall Square
  • B200, Third Floor
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Be Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 05-Oct-2026 Completed Out of Business
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series C) 01-Oct-2024 Completed Generating Revenue
2. Early Stage VC (Series B) 14-Apr-2022 $130M $182M Completed Generating Revenue
1. Early Stage VC (Series A) 22-Oct-2020 $52M $52M Completed Generating Revenue
To view Be Biopharma’s complete valuation and funding history, request access »

Be Biopharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Be Biopharma’s complete cap table history, request access »

Be Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of engineered B-cell medicines intended to transform treatment for patients with serious diseases. The company
Drug Discovery
Cambridge, MA
84 As of 2025

Seattle, WA
 

Richmond, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Be Biopharma Competitors (23)

One of Be Biopharma’s 23 competitors is Immusoft, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immusoft Venture Capital-Backed Seattle, WA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Ayala Pharmaceuticals Corporation Wilmington, DE
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 23 competitors. Get the full list »

Be Biopharma Patents

Be Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025240349-A2 Allogeneic cell compositions and methods thereof Pending 15-May-2024
WO-2025240349-A3 Allogeneic cell compositions and methods thereof Pending 15-May-2024
WO-2025240349-A8 Allogeneic cell compositions and methods thereof Pending 15-May-2024
AU-2024369860-A1 Engineered cell preparations for treatment of hypophosphatasia Pending 02-Nov-2023
EP-4801522-A2 Engineered cell preparations for treatment of hypophosphatasia Pending 02-Nov-2023 C12N9/16
To view Be Biopharma’s complete patent history, request access »

Be Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Be Biopharma FAQs

  • When was Be Biopharma founded?

    Be Biopharma was founded in 2020.

  • Where is Be Biopharma headquartered?

    Be Biopharma is headquartered in Cambridge, MA.

  • What is the size of Be Biopharma?

    Be Biopharma has 84 total employees.

  • What industry is Be Biopharma in?

    Be Biopharma’s primary industry is Drug Discovery.

  • Is Be Biopharma a private or public company?

    Be Biopharma is a Private company.

  • What is Be Biopharma’s current revenue?

    The current revenue for Be Biopharma is .

  • How much funding has Be Biopharma raised over time?

    Be Biopharma has raised $274M.

  • Who are Be Biopharma’s competitors?

    Immusoft, Sangamo Therapeutics, Ayala Pharmaceuticals, Allogene Therapeutics, and Kite Pharma are some of the 23 competitors of Be Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process